TARS Operating Expenses
Tarsus Pharmaceuticals Inc · Operating Expenses
TARS Operating Expenses
Latest reported$181.71Mperiod ending
TARS Quarterly Operating Expenses (-$337.50K → $181.71M)
Quarterly operating expenses
High-resolution chart · PNG
TARS operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 181,707,000 | |
| 158,780,000 | |
| 148,717,000 | |
| 108,633,000 | |
| 118,607,000 | |
| 99,404,000 | |
| 85,903,000 | |
| 70,038,000 | |
| 71,111,000 | |
| 63,644,000 | |
| 56,310,000 | |
| 42,429,000 | |
| 32,505,000 | |
| 27,197,000 | |
| 24,661,000 | |
| 22,695,000 | |
| 19,979,000 | |
| 20,027,000 | |
| 14,810,000 | |
| 16,880,000 | |
| 13,998,000 | |
| 21,421,000 | |
| 11,477,000 | |
| 10,141,000 | |
| 3,263,000 | |
| 2,118,000 | |
| 1,084,000 | |
| 613,000 | |
| -337,500 | |
| -337,500 |